VVT Med Inc.

As of June 30, 2026, VVT MED INC has 72.59M shares outstanding.

As of June 30, 2026, VVT MED INC maintains a current ratio of 0.16, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -63.70, indicating conservative leverage, while an interest coverage ratio of -25.57 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -382.85, reflecting losses generated across the asset base. Inventory turnover of 0.13 indicates how many times VVT MED INC sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, VVT MED INC generated 96,000.00 in revenue and converted that into -4.11M in net income, yielding earnings per share of -0.06. EBITDA reached -5.22M, while operating income came in at -5.37M.

As of June 30, 2026, VVT MED INC holds 9,000.00 in cash and equivalents against 1.17M in total debt, resulting in a net debt position of 669,000.00. Total book value stands at -1.83M, with working capital of -2.02M providing operational flexibility.

VVT MED INC produced -3.28M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -5,000.00 in capital expenditures, free cash flow totaled -3.29M - equivalent to -0.05 per share.

Over the twelve months ended June 30, 2026, VVT MED INC posted a gross margin of 63.54, reflecting its pricing power and cost economics. The operating margin of -5,592.71 and net profit margin of -4,279.17 provide insight into operational efficiency.

VVT MED INC's most recent stock split took place on July 31, 2025.